On ECHEMI
Home > Drugs > Guangxi Wuzhou Pharmaceuticals (GROUP) Co., Ltd.
Guangxi Wuzhou Pharmaceuticals (GROUP) Co., Ltd.
  • Founded in:

    1996-12-30
  • Country:

    China China
  • Address:

    No. 1 Industrial Avenue, Wuzhou Industrial Park, Guangxi
  • Tax NO.:

    91450400199135593A
  • Registered Funds:

    538.578622 million yuan
  • Website:

  • Email:

Related Drugs
Children's accumulation
Quisqualis, Guanzhong, Pomegranate peel, Areca nut, Leiwan, Pharbitis seeds, Stemona, Aucklandia, Poria, Chinese yam, Licorice
Name Description Content CAS NO. Registered Holders
Quisqualis

0
Cyrtomium fortunei

0
Pomegranate Extract Ellagic acid 40% HPLC

0
Arecae Semen

0
β-NADPH-D

74784-45-5 0
Pharbitidis Semen

0
STEMONAE RADIX

0
Aucklandiae Radix

0
Poria

0
Wild Yam P.E Diosgenine 7%-16%

0
DGL

0
Niuhuang Qingre San
Bezoar, Coptis chinensis, Scutellaria baicalensis, Gardenia jasminoides, Curcuma aromatica, Cold water stone, buffalo horn concentrate powder, amber powder, tortoise shell powder, cinnabar, borneol.
Name Description Content CAS NO. Registered Holders
CALCULUS BOVIS

0
COPTIDISRHIZOMA

0
RADIX SCUTELLARIAE

0
Gardeniae Fructus

0
CURCUMAE RADIX

0
Cold water stone extract

0
water buffalo horn power

0
AMBER POWDER

0
Tortoiseshell powder

0
Mercury(II) sulfide

1344-48-5 0
Borneol

507-70-0 1
Acacia phenol powder
This product is a compound preparation, each package contains 230 mg of aspirin, 126 mg of acetaminophen, and 30 mg of caffeine.
Name Description Content CAS NO. Registered Holders
Acetylsalicylic acid

Inhibits prostaglandin synthesis and has antipyretic and analgesic effects

More

Inhibits prostaglandin synthesis and has antipyretic and analgesic effects

230mg 50-78-2 35
Acetaminophen

Inhibits prostaglandin synthesis and has antipyretic and analgesic effects

More

Inhibits prostaglandin synthesis and has antipyretic and analgesic effects

126mg 103-90-2 68
Caffeine

Central nervous system stimulants that can enhance the antipyretic and analgesic effects of drugs

More

Central nervous system stimulants that can enhance the antipyretic and analgesic effects of drugs

30mg 0
Erythromycin Lactobionate for Injection
Erythromycin lactobionate
Name Description Content CAS NO. Registered Holders
ERYTHROMYCIN LACTOBIONATE (200 MG)

This product belongs to the macrolide antibiotics, which is a water-soluble erythromycin lactobionate. It has antibacterial activity against Staphylococcus, various groups of streptococci and Gram-positive bacilli. Neisseria, Haemophilus influenzae, Bordetella pertussis, etc. may also be sensitive to this product. This product also has antibacterial activity against various anaerobic bacteria except Bacteroides fragilis and Fusobacterium; it also has inhibitory effects on Legionella, Campylobacter fetus, some spirochetes, Mycoplasma pneumoniae, Rickettsia and Chlamydia. This product is an antibacterial agent, but it also has a bactericidal effect on some Newbacteria at high concentrations. This product can pass through the bacterial cell membrane and reversibly bind to the 50S subunit of the bacterial ribosome near the donor site (P site), blocking the transfer RNA (l-RNA) binding to the P site, and also blocking the displacement of the polypeptide chain from the acceptor site (A site) to the P site, thereby inhibiting bacterial protein synthesis. Erythromycin is only effective against bacteria that actively divide.

More

This product belongs to the macrolide antibiotics, which is a water-soluble erythromycin lactobionate. It has antibacterial activity against Staphylococcus, various groups of streptococci and Gram-positive bacilli. Neisseria, Haemophilus influenzae, Bordetella pertussis, etc. may also be sensitive to this product. This product also has antibacterial activity against various anaerobic bacteria except Bacteroides fragilis and Fusobacterium; it also has inhibitory effects on Legionella, Campylobacter fetus, some spirochetes, Mycoplasma pneumoniae, Rickettsia and Chlamydia. This product is an antibacterial agent, but it also has a bactericidal effect on some Newbacteria at high concentrations. This product can pass through the bacterial cell membrane and reversibly bind to the 50S subunit of the bacterial ribosome near the donor site (P site), blocking the transfer RNA (l-RNA) binding to the P site, and also blocking the displacement of the polypeptide chain from the acceptor site (A site) to the P site, thereby inhibiting bacterial protein synthesis. Erythromycin is only effective against bacteria that actively divide.

3847-29-8 17
Erythromycin Lactobionate for Injection
Erythromycin lactobionate
Name Description Content CAS NO. Registered Holders
ERYTHROMYCIN LACTOBIONATE (200 MG)

This product belongs to the macrolide antibiotics, which is a water-soluble erythromycin lactobionate. It has antibacterial activity against Staphylococcus, various groups of streptococci and Gram-positive bacilli. Neisseria, Haemophilus influenzae, Bordetella pertussis, etc. may also be sensitive to this product. This product also has antibacterial activity against various anaerobic bacteria except Bacteroides fragilis and Fusobacterium; it also has inhibitory effects on Legionella, Campylobacter fetus, some spirochetes, Mycoplasma pneumoniae, Rickettsia and Chlamydia. This product is an antibacterial agent, but it also has a bactericidal effect on some Newbacteria at high concentrations. This product can pass through the bacterial cell membrane and reversibly bind to the 50S subunit of the bacterial ribosome near the donor site (P site), blocking the transfer RNA (l-RNA) binding to the P site, and also blocking the displacement of the polypeptide chain from the acceptor site (A site) to the P site, thereby inhibiting bacterial protein synthesis. Erythromycin is only effective against bacteria that actively divide.

More

This product belongs to the macrolide antibiotics, which is a water-soluble erythromycin lactobionate. It has antibacterial activity against Staphylococcus, various groups of streptococci and Gram-positive bacilli. Neisseria, Haemophilus influenzae, Bordetella pertussis, etc. may also be sensitive to this product. This product also has antibacterial activity against various anaerobic bacteria except Bacteroides fragilis and Fusobacterium; it also has inhibitory effects on Legionella, Campylobacter fetus, some spirochetes, Mycoplasma pneumoniae, Rickettsia and Chlamydia. This product is an antibacterial agent, but it also has a bactericidal effect on some Newbacteria at high concentrations. This product can pass through the bacterial cell membrane and reversibly bind to the 50S subunit of the bacterial ribosome near the donor site (P site), blocking the transfer RNA (l-RNA) binding to the P site, and also blocking the displacement of the polypeptide chain from the acceptor site (A site) to the P site, thereby inhibiting bacterial protein synthesis. Erythromycin is only effective against bacteria that actively divide.

3847-29-8 17
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.